This course has expired. View available courses.
English
Advances in the diagnosis and management of Alzheimer’s disease – Specialists – QI&CPD – Category 2
DURATION
PROFESSION
Physician
# OF CREDITS
4
ACCREDITATION
EXPIRY DATE
2016-04-11
Learning objectives
On completion of the learning module, participants will be better able to:
- Identify the specific memory and cognitive features that raise suspicion for Alzheimer’s disease (AD) and to be able to recognise and distinguish AD from other forms of dementia.
- Review criteria for the diagnosis of AD and other forms of dementia:
- Vascular dementia
- Frontotemporal lobar degeneration (FTLD)
- Corticobasal degeneration
- Multiple system atrophy
- Review criteria for the diagnosis of AD and other forms of dementia:
- Interpret the results of various cognitive screening tools used in patients with suspected dementia (MoCA, MMSE, and RUDAS).
- Set management goals of patients with AD, including initial, long-term, and follow-up care.
- Understand current research regarding the factors associated with AD (smoking, cardiovascular disease) and the recommendations for AD prevention.
- Review and summarise new drug treatment trials.
# of credits: 4
Duration:
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
